CCM
IDNA icon

Cribstone Capital Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Cribstone Capital Management’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$17.6K Buy
+700
New +$18.8K 0.01% 213

Other funds holding IDNA

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $6.46B AUM 18.45% 1-Year Est. Return

Cribstone Capital Management's IDNA Position: Q4 2022 in Review

Cribstone Capital Management opened a new position in iShares Genomics Immunology and Healthcare ETF (IDNA) in Q4 2022: 700 shares worth $17.6K. The stake represents 0.01% of the portfolio and ranks #213 among its holdings.

75 funds tracked by Wall St. Rank hold IDNA as of Q4 2022.

  • Cribstone Capital Management held 700 shares of iShares Genomics Immunology and Healthcare ETF worth $17.6K as of Q4 2022.
  • iShares Genomics Immunology and Healthcare ETF was a new Cribstone Capital Management position in Q4 2022.
  • iShares Genomics Immunology and Healthcare ETF made up 0.01% of Cribstone Capital Management's portfolio in Q4 2022, its #213 holding.
  • 75 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q4 2022.

Based on Cribstone Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.